YVETTE CISNEROS: Open Payments
NPI 1336624006 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 7 payments from 5 companies in 2025. Trend: 2023 $88 · 2024 $178 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $161 |
| Teva Pharmaceuticals USA, Inc. | 2 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $17 |
Products named: REXULTI, UZEDY, CAPLYTA, FANAPT, ARISTADA.
Industry payments across TX — which companies pay providers there.
